𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

✍ Scribed by Bing-Sheng Sun; Qiong-Zhu Dong; Qing-Hai Ye; Hai-Jing Sun; Hu-Liang Jia; Xiao-Qun Zhu; Dao-Yong Liu; Jie Chen; Qiong Xue; Hai-Jun Zhou; Ning Ren; Lun-Xiu Qin


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
398 KB
Volume
48
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


In our previous study, osteopontin (OPN) was identified as one of the leading genes that promote the metastasis of hepatocellular carcinoma (HCC). However, the mechanism by which OPN promotes metastasis of HCC is not understood. In this study, RNA interference mediated by viral vectors-which could induce a long-lasting down-regulation in gene expression-was applied to analyze the role of OPN in metastasis of HCC. Three lentiviral vectors encoding microRNA against OPN, Lenti.OPNi-1, Lenti.OPNi-2, and Lenti.OPNi-3, were constructed and found to down-regulate the OPN level by 62%, 78%, and 95%, respectively, in HCCLM3 cells which had an overexpression of OPN and a higher metastatic potential. Consequently, both Lenti.OPNi-2 and Lenti.OPNi-3 induced a significant decrease in matrix metalloproteinase (MMP)-2 and urokinase plasminogen activator expression, and led to an obvious inhibition of both in vitro invasion and in vivo lung metastasis of HCCLM3 cells (P < 0.001). Moreover, Lenti.OPNi-3, rather than Lenti.OPNi-2, could also suppress in vitro proliferation and in vivo tumor growth of HCCLM3. Smaller detectable tumors were found in only 50% of mice after implantation of Lenti.OPNi-3-transfected HCCLM3 cells (341 +/- 502.6 mm(3) versus >3500 mm(3) in controls; P < 0.001). Lenti.OPNi-3, not Lenti.OPNi-2, significantly suppressed the MEK/ERK1/2 pathway in HCCLM3 cells. Recombinant OPN was found to induce translocation of p65 into the nucleus of HCC cells and activation of MMP-2 and MEK/ERK/1/2, which were suppressed by the nuclear factor kappaB (NF-kappaB) inhibitor pyrrolidine dithiocarbamate.

Conclusion:

Opn plays an important role in metastasis as well as tumor growth of hcc, in which different minimum threshold levels of opn are needed. these effects may occur through activation of the mitogen-activated protein kinase and nf-kappab pathways, and mmp-2. opn could be a hopeful target for the control of hcc.


📜 SIMILAR VOLUMES


NKT and CD8 lymphocytes mediate suppress
✍ Oren Shibolet; Ruslana Alper; Lydia Zlotogarov; Barbara Thalenfeld; Dean Engelha 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract Dendritic cells (DCs) are antigen presenting cells that play a role in T‐cell activation. Liver‐associated natural killer T lymphocytes (NKTs) are a unique subset of lymphocytes that may be important in antitumor immunity. Hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HCC

Tissue-specific growth suppression and c
✍ G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for

Targeted disruption of Nemo-like kinase
✍ Kwang Hwa Jung; Jeong Kyu Kim; Ji Heon Noh; Jung Woo Eun; Hyun Jin Bae; Hong Jia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Wnt/β‐catenin signaling pathway regulates various aspects of development and plays important role in human carcinogenesis. Nemo‐like kinase (NLK), which is mediator of Wnt/β‐catenin signaling pathway, phosphorylates T‐cell factor/lymphoid enhancer factor (TCF/LEF) factor and inhibit